DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xrdnxd/global) has announced the addition of the "Global Therapeutic Vaccines Market 2014-2018" report to their offering.
The Global Therapeutic Vaccines market to grow at a CAGR of 62.81 percent over the period 2013-2018.
The increase in technological advances and improved understanding of immunology and immunotherapy has enabled the discovery of many biomarkers, thus aiding the development of therapy through the body's natural defense mechanism. Vaccines are usually thought of as biologics, which elicit an immune response to initiate a defense mechanism. This led to the development of therapeutic vaccines, which can induce the immune system to attack the targeted diseased tissue with greater bioavailability and specificity with minimal side effects. Various strategies have been developed to make therapeutic vaccines viable alternatives to the existing therapeutic approaches. Thus, improved understanding of immunology and immunotherapy is expected to boost the growth of the Global Therapeutic Vaccines market.
According to the report, the incidence of cancers, infectious diseases, and physiological disorders is widespread owing to poor lifestyle, low immunity, and unhygienic conditions. As a result, the incidence of disorders such as Alzheimer's disease, Parkinson's disease, cancer, diabetes, and infectious diseases such as Hepatitis B, HIV/AIDS, and HPV is rising. The manifestation of these ailments is expected to increase due to a rise in aging population. The use of these vaccines to treat such ailments will be boosted by an increase in prevalence of these diseases and disorders, thus boosting the growth of the market.
Further, the report states that the stringent government regulations could lead to delays in production and additional manufacturing costs. Vendors transfer the burden of the extra costs onto the end-users, making the adoption of the vaccines challenging.
Key Vendors
- Agenus Inc.
- Bavarian Nordic A/S.
- Dendreon Corp.
- GlaxoSmithKline plc
- Novartis International AG
Other Prominent Vendors
- AFFiRiS AG.
- Argos Therapeutics Inc.
- Celldex Therapeutics Inc.
- CEL-SCI Corp.
- Cytos Biotechnology AG
- GlobeImmune Inc.
- NewLink Genetics Corp.
- NovaRx Corp.
- Oncothyreon Inc.
- TVAX Biomedical Inc.
- TapImmune Inc.
- Vical Inc.
- Vaccinogen Inc.
Market Drivers/Trends/Challenges
- Increase in Incidence of Cancer, Infectious Diseases, and Physiological Disorders
- Ongoing Development of a Large Number of Therapeutic Vaccines
- Stringent Regulations
- Adverse Side Effects of Therapeutic Vaccines
-
Increase in Mergers and Acquisitions
Key Topics Covered:
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Market Research Methodology
- Introduction
- Market Landscape
- Geographical Segmentation
- Key Leading Countries
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Pipeline Analysis
- Vendor Landscape
- Key Vendor Analysis
For more information visit http://www.researchandmarkets.com/research/xrdnxd/global
